{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:43:31Z","timestamp":1792514611120,"version":"4.5.0"},"reference-count":47,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"unspecified","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2022LJ016"],"award-info":[{"award-number":["2022LJ016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030045"],"award-info":[{"award-number":["82030045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473288"],"award-info":[{"award-number":["82473288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92478203"],"award-info":[{"award-number":["92478203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Collaborative Innovation Center for Clinical and Translational Science by Ministry of Education & Shanghai","award":["CCTS-202407PT"],"award-info":[{"award-number":["CCTS-202407PT"]}]},{"name":"Collaborative Innovation Center for Clinical and Translational Science by Ministry of Education & Shanghai","award":["CCTS-202508PT"],"award-info":[{"award-number":["CCTS-202508PT"]}]},{"name":"Shanghai Chest Hospital Basic Research Project","award":["2023YNKT-1"],"award-info":[{"award-number":["2023YNKT-1"]}]},{"name":"Shanghai Key Laboratory of Thoracic Tumor Biotherapy","award":["2025SZ1710"],"award-info":[{"award-number":["2025SZ1710"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,9,21]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/jitc-2026-015974","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:10:20Z","timestamp":1792512620000},"page":"e015974","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["PCSK9 drives acquired resistance to anti-PD-1 immunotherapy through cystine metabolic reprogramming in lung cancer"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-6280","authenticated-orcid":false,"given":"Guangling","family":"Jie","sequence":"first","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqi","family":"Cao","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingze","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Lu","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Immunology, Department of Immunology and Microbiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8833-7262","authenticated-orcid":false,"given":"Shun","family":"Lu","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliang","family":"Xia","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"2026102009100630000_14.10.e015974.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01989"},{"key":"2026102009100630000_14.10.e015974.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32409-7"},{"key":"2026102009100630000_14.10.e015974.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.12.013"},{"key":"2026102009100630000_14.10.e015974.4","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005920","article-title":"Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy","volume":"11","author":"Rizvi","year":"2023","journal-title":"J Immunother Cancer"},{"key":"2026102009100630000_14.10.e015974.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.03.017"},{"key":"2026102009100630000_14.10.e015974.6","unstructured":"National Comprehensive Cancer Network . NCCN clinical practice guidelines in oncology: non\u2013small cell lung cancer. 2025. Available: https:\/\/www.nccn.org\/guidelines\/nccn-guidelines"},{"key":"2026102009100630000_14.10.e015974.7","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0593"},{"key":"2026102009100630000_14.10.e015974.8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01062-w","article-title":"Resistance to checkpoint blockade therapy through inactivation of antigen presentation","volume":"8","author":"Sade-Feldman","year":"2017","journal-title":"Nat Commun"},{"key":"2026102009100630000_14.10.e015974.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.11.022"},{"key":"2026102009100630000_14.10.e015974.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.07.019"},{"key":"2026102009100630000_14.10.e015974.11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733"},{"key":"2026102009100630000_14.10.e015974.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00580"},{"key":"2026102009100630000_14.10.e015974.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01026-4"},{"key":"2026102009100630000_14.10.e015974.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06299-8"},{"key":"2026102009100630000_14.10.e015974.15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38316-9","article-title":"Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells","volume":"14","author":"Pandit","year":"2023","journal-title":"Nat Commun"},{"key":"2026102009100630000_14.10.e015974.16","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-06503-1","article-title":"Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8+ T cells","volume":"15","author":"Han","year":"2024","journal-title":"Cell Death Dis"},{"key":"2026102009100630000_14.10.e015974.17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409736102"},{"key":"2026102009100630000_14.10.e015974.18","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202408514","article-title":"PCSK9 Promotes the Malignancy of Triple\u2010negative Breast Cancer Cells by Reducing Cholesterol Levels at the Plasma Membrane to Activate EGFR and HER3","volume":"12","author":"Li","year":"2025","journal-title":"Advanced Science"},{"key":"2026102009100630000_14.10.e015974.19","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01690-3","article-title":"Targeting proprotein convertase subtilisin\/kexin type 9 (PCSK9): from bench to bedside","volume":"9","author":"Bao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2026102009100630000_14.10.e015974.20","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00262-019-02367-z","article-title":"Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study","volume":"68","author":"Bonaventura","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"2026102009100630000_14.10.e015974.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2911-7"},{"key":"2026102009100630000_14.10.e015974.22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/cac2.70038","article-title":"Lipid metabolism reprograming by SREBP1\u2010PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy","volume":"45","author":"Lao","year":"2025","journal-title":"Cancer Commun"},{"key":"2026102009100630000_14.10.e015974.23","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-021-00821-2"},{"key":"2026102009100630000_14.10.e015974.24","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1038\/s41388-020-1207-6","article-title":"PTGES\/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model","volume":"39","author":"Wang","year":"2020","journal-title":"Oncogene"},{"key":"2026102009100630000_14.10.e015974.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0107-8"},{"key":"2026102009100630000_14.10.e015974.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00587-0"},{"key":"2026102009100630000_14.10.e015974.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32517-X"},{"key":"2026102009100630000_14.10.e015974.28","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2010.3496"},{"key":"2026102009100630000_14.10.e015974.29","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1016\/j.cell.2026.03.012","article-title":"Sulfur partitioning from cysteine controls T cell proliferation and effector function","volume":"189","author":"Kelly","year":"2026","journal-title":"Cell"},{"key":"2026102009100630000_14.10.e015974.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113295"},{"key":"2026102009100630000_14.10.e015974.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07943-7"},{"key":"2026102009100630000_14.10.e015974.32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.redox.2012.10.001","article-title":"The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer","volume":"1","author":"Kansanen","year":"2013","journal-title":"Redox Biol"},{"key":"2026102009100630000_14.10.e015974.33","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04307-1","article-title":"Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11","volume":"12","author":"Dong","year":"2021","journal-title":"Cell Death Dis"},{"key":"2026102009100630000_14.10.e015974.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00566-3"},{"key":"2026102009100630000_14.10.e015974.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01826-7","article-title":"Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies","volume":"22","author":"Muhammad","year":"2023","journal-title":"Mol Cancer"},{"key":"2026102009100630000_14.10.e015974.36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.062788"},{"key":"2026102009100630000_14.10.e015974.37","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332429"},{"key":"2026102009100630000_14.10.e015974.38","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.cmet.2025.08.009","article-title":"HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer","volume":"37","author":"Xiao","year":"2025","journal-title":"Cell Metab"},{"key":"2026102009100630000_14.10.e015974.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2682-1"},{"key":"2026102009100630000_14.10.e015974.40","doi-asserted-by":"crossref","first-page":"2501623","DOI":"10.1002\/advs.202501623","article-title":"Methionine Metabolism Dictates PCSK9 Expression and Antitumor Potency of PD\u20101 Blockade in MSS Colorectal Cancer","volume":"12","author":"Wang","year":"2025","journal-title":"Advanced Science"},{"key":"2026102009100630000_14.10.e015974.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-020-0496-x"},{"key":"2026102009100630000_14.10.e015974.42","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw9872"},{"key":"2026102009100630000_14.10.e015974.43","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-018-0315-y"},{"key":"2026102009100630000_14.10.e015974.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2023.08.004"},{"key":"2026102009100630000_14.10.e015974.45","doi-asserted-by":"crossref","DOI":"10.1126\/science.ade8520","article-title":"JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma","volume":"384","author":"Zak","year":"2024","journal-title":"Science"},{"key":"2026102009100630000_14.10.e015974.46","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf1329","article-title":"Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients","volume":"384","author":"Mathew","year":"2024","journal-title":"Science"},{"key":"2026102009100630000_14.10.e015974.47","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2025.102017","article-title":"Interferon-\u03b3-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancer","volume":"6","author":"Cao","year":"2025","journal-title":"Cell Rep Med"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-015974","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:10:23Z","timestamp":1792512623000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-015974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,20]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/jitc-2026-015974"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-015974","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}